TriSalus Life Sciences (TLSIW) Accumulated Expenses (2020 - 2026)

TriSalus Life Sciences (TLSIW) has 7 years of Accumulated Expenses data on file, last reported at $7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 15.9% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (down 15.9% YoY), and the FY2025 full-year result was $8.1 million, up 10.07% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $7.1 million, down from $8.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $11.4 million in Q1 2024 and bottomed at $6.4 million in Q4 2022.
• The 5-year median for Accumulated Expenses is $7.6 million (2024), against an average of $8.1 million.
• The widest annual swing landed in 2023, when Accumulated Expenses soared 65.53%; it then slumped 30.32% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $6.4 million in 2022, then jumped by 65.53% to $10.6 million in 2023, then slumped by 30.32% to $7.4 million in 2024, then grew by 10.07% to $8.1 million in 2025, then retreated by 12.71% to $7.1 million in 2026.
• The last three Accumulated Expenses figures came in at $7.1 million (Q1 2026), $8.1 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.

Peer Comparison